Emergent BioSolutions Inc. (EBS)

NYSE: EBS · Real-Time Price · USD

7.16

+0.22 (3.17%)

At close: Jul 22, 2025, 4:00 PM

7.08

-0.08 (-1.12%)

After-hours: Jul 22, 2025, 7:52 PM EDT

Emergent BioSolutions Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	965.4	1,044	1,049	1,118	1,774	1,577	Upgrade
Revenue Growth (YoY)	-18.56%	-0.54%	-6.10%	-36.99%	12.45%	42.61%	Upgrade
Cost of Revenue	611.4	668.2	689.3	644.5	980.4	714.2	Upgrade
Gross Profit	354	375.4	360	473	793.2	863.1	Upgrade
Selling, General & Admin	266.6	298.7	356.7	339.5	348.7	304.1	Upgrade
Research & Development	63.8	63.8	105.8	182.9	-	-	Upgrade
Operating Expenses	395.6	427.6	528.1	582.3	407.2	363.9	Upgrade
Operating Income	-41.6	-52.2	-168.1	-109.3	386	499.2	Upgrade
Interest Expense	-61.4	-71	-87.9	-37.3	-34.5	-31.3	Upgrade
Other Non Operating Income (Expenses)	78.3	13.1	8.9	-11.7	-3.7	4.7	Upgrade
EBT Excluding Unusual Items	-24.7	-110.1	-247.1	-158.3	347.8	472.6	Upgrade
Merger & Restructuring Charges	-56.9	-55.9	-33.2	-51.4	-	-	Upgrade
Impairment of Goodwill	-	-	-218.2	-6.7	-41.7	-	Upgrade
Gain (Loss) on Sale of Assets	20	24.3	74.2	-	-	-	Upgrade
Asset Writedown	-	-	-306.7	-	-	-29	Upgrade
Other Unusual Items	-0.7	-1.2	-0.2	-2.6	-2.9	-31.7	Upgrade
Pretax Income	-62.3	-142.9	-731.2	-219	303.2	411.9	Upgrade
Income Tax Expense	69.3	47.7	29.3	-7.4	83.7	106.1	Upgrade
Earnings From Continuing Operations	-131.6	-190.6	-760.5	-211.6	219.5	305.8	Upgrade
Net Income	-131.6	-190.6	-760.5	-211.6	219.5	305.8	Upgrade
Net Income to Common	-131.6	-190.6	-760.5	-211.6	219.5	305.8	Upgrade
Net Income Growth	-	-	-	-	-28.22%	461.10%	Upgrade
Shares Outstanding (Basic)	54	53	51	50	54	53	Upgrade
Shares Outstanding (Diluted)	54	53	51	50	54	54	Upgrade
Shares Change (YoY)	3.58%	3.52%	2.20%	-7.39%	0.56%	2.67%	Upgrade
EPS (Basic)	-2.46	-3.60	-14.85	-4.22	4.10	5.80	Upgrade
EPS (Diluted)	-2.46	-3.60	-14.85	-4.22	4.06	5.68	Upgrade
EPS Growth	-	-	-	-	-28.52%	446.15%	Upgrade
Free Cash Flow	94.4	35.8	-257.9	-149.9	96.1	395	Upgrade
Free Cash Flow Per Share	1.76	0.68	-5.04	-2.99	1.78	7.34	Upgrade
Gross Margin	36.67%	35.97%	34.31%	42.33%	44.72%	54.72%	Upgrade
Operating Margin	-4.31%	-5.00%	-16.02%	-9.78%	21.76%	31.65%	Upgrade
Profit Margin	-13.63%	-18.26%	-72.48%	-18.93%	12.38%	19.39%	Upgrade
Free Cash Flow Margin	9.78%	3.43%	-24.58%	-13.41%	5.42%	25.04%	Upgrade
EBITDA	61.8	53.4	-47	15.7	504.2	609.2	Upgrade
EBITDA Margin	6.40%	5.12%	-4.48%	1.41%	28.43%	38.62%	Upgrade
D&A For EBITDA	103.4	105.6	121.1	125	118.2	110	Upgrade
EBIT	-41.6	-52.2	-168.1	-109.3	386	499.2	Upgrade
EBIT Margin	-4.31%	-5.00%	-16.02%	-9.78%	21.76%	31.65%	Upgrade
Effective Tax Rate	-	-	-	-	27.61%	25.76%	Upgrade
Revenue as Reported	965.4	1,044	1,049	1,118	1,774	1,577	Upgrade

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q